Primitive AML progenitors from most CD34+ patients lack CD33 expression but progenitors from many CD34- AML patients express CD33

By Vercauteren Sm   Zapf R.   Sutherland Hj  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 194-204

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Individual and synergistic cytokine effects controlling the expansion of cord blood CD34⁺⁺ cells and megakaryocyte progenitors in culture

By Pineault Nicolas   Cortin Valéérie   Boyer Lucie   Garnier Alain   Robert Améélie   Théérien Cynthia   Roy Denis-Claude  

Cytotherapy, Vol. 13, Iss. 4, 2011-04 ,pp. : 467-480

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34⁺ peripheral blood progenitor cells

By Veldwijk Marlon R.   Sellner Leopold   Stiefelhagen Marius   Kleinschmidt Jürgen A.   Laufs Stephanie   Topaly Julian   Fruehauf Stefan   Zeller W. Jens   Wenz Frederik  

Cytotherapy, Vol. 12, Iss. 1, 2010-01 ,pp. : 107-112

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Australasian CD34⁺ quality assurance program and rationale for the clinical utility of the single-platform method for CD34⁺ cell enumeration

By Chang A   Raik E   Marsden K   Ma Ddf  

Cytotherapy, Vol. 6, Iss. 1, 2004-01 ,pp. : 50-61

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The CD34⁺ Cell Concentration in Peripheral Blood Predicts CD34⁺ Cell Yield in the Leukapheresis Product

By Hollingsworth KL   Zimmerman TM   Karrison T   Oliver A   Williams SF  

Cytotherapy, Vol. 1, Iss. 2, 1999-01 ,pp. : 141-146

Ashgate Publishing Ltd

Access to resources Recommend Favorite